Unité de Fabrication des Médicaments S.A (BVMT:UMED)

BVMT:UMED Balance Sheet

Financials in millions TND. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	11.2	8.97	21.01	5.98	5.98	3.69
Cash & Short-Term Investments	11.2	8.97	21.01	5.98	5.98	3.69
Cash Growth	-43.60%	-57.33%	251.29%	0.06%	62.11%	26.21%
Accounts Receivable	40.54	36.67	36.65	39.46	33.94	26.39
Other Receivables	-4.09	15.74	14.36	8.52	10.37	7.85
Receivables	36.45	52.41	51.02	47.98	44.32	34.24
Inventory	45.05	46.45	47.64	50.22	44.14	34.59
Prepaid Expenses	-	0.4	0.31	0.5	0.46	0.19
Other Current Assets	20.63	4.31	5.56	8.74	5.49	4.42
Total Current Assets	113.34	118.13	129.08	113.42	100.38	77.13
Property, Plant & Equipment	72.05	75.53	79.71	74.9	71.67	66.46
Long-Term Investments	2.26	1.26	3.29	5.23	7.29	7.44
Other Intangible Assets	4.83	0.55	0.79	1.03	0.81	0.74
Long-Term Deferred Charges	-	3.89	2.45	1.08	1.43	0.07
Other Long-Term Assets	-	1.21	0.95	2.5	2.25	2.63
Total Assets	192.48	200.58	216.28	198.18	183.86	154.48

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	16.23	9.71	22.29	29.08	16.8	10.6
Accrued Expenses	-	19.06	17.5	20.55	6.4	5.55
Short-Term Debt	2.95	19.98	22.24	6.46	22.72	0.39
Current Portion of Long-Term Debt	-	7.12	7.72	22.91	6.95	5.33
Current Portion of Leases	-	0.86	0.88	-	0.22	0.39
Current Unearned Revenue	-	-	0.13	0.02	-	-
Other Current Liabilities	51.79	0.03	0.1	0.71	0.02	0.01
Total Current Liabilities	70.98	56.82	70.85	79.74	53.11	22.27
Long-Term Debt	14.34	17.11	23.57	21.83	25.25	21.62
Long-Term Leases	-	0.48	1.34	0.33	0.08	0.3
Other Long-Term Liabilities	7.05	9.62	4.31	2.02	1.73	1.45
Total Liabilities	92.36	84.03	100.07	103.93	80.17	45.64

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	32	32	32	32	32	32
Retained Earnings	19.96	69.37	69.01	47.03	56.49	61.66
Comprehensive Income & Other	48.15	15.18	15.2	15.23	15.21	15.17
Shareholders' Equity	100.11	116.54	116.21	94.25	103.7	108.83
Total Liabilities & Equity	192.48	200.58	216.28	198.18	183.86	154.48

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	17.29	45.56	55.74	51.53	55.22	28.03
Net Cash (Debt)	-6.09	-36.59	-34.73	-45.55	-49.24	-24.34
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-	-1.14	-1.09	-1.42	-1.54	-0.76
Filing Date Shares Outstanding	-	32	32	32	32	32
Total Common Shares Outstanding	-	32	32	32	32	32
Working Capital	42.36	61.3	58.23	33.68	47.28	54.85
Book Value Per Share	-	3.64	3.63	2.95	3.24	3.40
Tangible Book Value	95.28	116	115.42	93.23	102.88	108.1
Tangible Book Value Per Share	-	3.62	3.61	2.91	3.22	3.38
Land	-	4.22	4.22	4.22	4.22	4.22
Buildings	-	10.92	10.92	8.72	10.68	10.62
Machinery	-	140.89	141.04	131.46	30.77	28.9
Construction In Progress	-	49.41	46.61	43.89	25.93	19.43

Data Source: S&P Global Market Intelligence Last updated: May 20, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 24, 2026

Data Sources Report a data error